Efficacy and safety of immunoglobulin retreatment in Kawasaki disease

J Pediatr. 1994 Oct;125(4):672-3. doi: 10.1016/s0022-3476(94)70043-5.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Adolescent
  • Child
  • Child, Preschool
  • Coronary Disease / etiology
  • Female
  • Humans
  • Immunoglobulins, Intravenous / therapeutic use*
  • Infant
  • Male
  • Mucocutaneous Lymph Node Syndrome / complications
  • Mucocutaneous Lymph Node Syndrome / therapy*
  • Recurrence

Substances

  • Immunoglobulins, Intravenous